I disagree. Obviously part of the market is looking at future potential/res/profit and it's pretty obvious by the end of 2017 TRTC will be making boatloads of cash and will be very profitable, just based on Blum, IVXX and 4 dispensaries carrying their own brands grown and made by themselves. Not to mention all the possible new acquisitions etc. in between that time.